<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font17">for </span>
   <span class="font13">referral </span>
   <span class="font13">European </span>
   <span class="font13">The </span>
   <span class="font13">with </span>
   <span class="font12">antibiotics </span>
   <span class="font12">that </span>
   <span class="font12">use </span>
   <span class="font12">were </span>
   <span class="font12">{background </span>
   <span class="font12">product </span>
   <span class="font12">was </span>
   <span class="font11">patients </span>
   <span class="font11">margin </span>
   <span class="font11">changes </span>
   <span class="font11">medicinal </span>
   <span class="font11">{border-style </span>
   <span class="font11">information </span>
   <span class="font11">procedures </span>
   <span class="font11">px;} </span>
   <span class="font11">section </span>
   <span class="font11">therapeutic </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">regulatory </span>
   <span class="font11">treatment </span>
   <span class="font11">Available </span>
   <span class="font11">from </span>
   <span class="font11">from: </span>
   <span class="font11">Article </span>
   <span class="font11">[]. </span>
   <span class="font11">specific </span>
   <span class="font11">SmPC </span>
   <span class="font11">infections </span>
   <span class="font11">products </span>
   <span class="font11">all </span>
   <span class="font11">cefuroxime </span>
   <span class="font11">important </span>
   <span class="font11">procedure </span>
   <span class="font11">study </span>
   <span class="font11">antibiotic </span>
   <span class="font11">made </span>
   <span class="font10">indications </span>
   <span class="font10">most </span>
   <span class="font10">sodium </span>
   <span class="font10">For </span>
   <span class="font10">antimicrobial </span>
   <span class="font10">are </span>
   <span class="font10">between </span>
   <span class="font10">clinical </span>
   <span class="font10">included </span>
   <span class="font10">method </span>
   <span class="font10">Changes </span>
   <span class="font10">characteristics </span>
   <span class="font10">colistin/colistimethate </span>
   <span class="font10">during </span>
   <span class="font10">may </span>
   <span class="font10">Union </span>
   <span class="font10">also </span>
   <span class="font10">appropriate </span>
   <span class="font10">available </span>
   <span class="font10">disease </span>
   <span class="font10">dosage </span>
   <span class="font10">harmonisation </span>
   <span class="font10">indication </span>
   <span class="font10">marketing </span>
   <span class="font10">one </span>
   <span class="font10">px; </span>
   <span class="font10">result </span>
   <span class="font10">scientific </span>
   <span class="font10">sodium, </span>
   <span class="font10">such </span>
   <span class="font10">this </span>
   <span class="font10">tract </span>
   <span class="font10">use. </span>
   <span class="font10">warnings </span>
   <span class="font10">{font-family </span>
   <span class="font10">Deletion </span>
   <span class="font10">Health </span>
   <span class="font10">Member </span>
   <span class="font10">administration </span>
   <span class="font10">antibiotics. </span>
   <span class="font10">can </span>
   <span class="font10">contributed </span>
   <span class="font10">data </span>
   <span class="font10">font-size </span>
   <span class="font10">function </span>
   <span class="font10">have </span>
   <span class="font10">healthcare </span>
   <span class="font10">impact </span>
   <span class="font10">indication, </span>
   <span class="font10">majority </span>
   <span class="font10">outcome </span>
   <span class="font10">procedures. </span>
   <span class="font10">referrals </span>
   <span class="font10">renal </span>
   <span class="font10">resistance </span>
   <span class="font10">summary </span>
   <span class="font10">two </span>
   <span class="font10">(ATC </span>
   <span class="font10">Centre </span>
   <span class="font10">This </span>
   <span class="font10">acid, </span>
   <span class="font10">deletion </span>
   <span class="font10">double; </span>
   <span class="font10">following </span>
   <span class="font10">has </span>
   <span class="font10">medicines </span>
   <span class="font10">not </span>
   <span class="font10">reduced </span>
   <span class="font10">regarding </span>
   <span class="font10">respiratory </span>
   <span class="font10">revised </span>
   <span class="font10">â€" </span>
   <span class="font10">;():-. </span>
   <span class="font10">AMR </span>
   <span class="font10">Antimicrobial </span>
   <span class="font10">Commission </span>
   <span class="font10">Control </span>
   <span class="font10">Directive </span>
   <span class="font10">Disease </span>
   <span class="font10">Medicines </span>
   <span class="font10">October </span>
   <span class="font10">Prevention </span>
   <span class="font10">Society </span>
   <span class="font10">[Accessed: </span>
   <span class="font10">acute </span>
   <span class="font10">adjustment </span>
   <span class="font10">amendments </span>
   <span class="font10">among </span>
   <span class="font10">amoxicillin/clavulanic </span>
   <span class="font10">analysis </span>
   <span class="font10">authorisation </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">ceftriaxone, </span>
   <span class="font10">classes </span>
   <span class="font10">critically </span>
   <span class="font10">different </span>
   <span class="font10">human </span>
   <span class="font10">lower </span>
   <span class="font10">manuscript </span>
   <span class="font10">number </span>
   <span class="font10">paediatric </span>
   <span class="font10">polymyxins </span>
   <span class="font10">posology </span>
   <span class="font10">practice. </span>
   <span class="font10">professionals </span>
   <span class="font10">prophylactic </span>
   <span class="font10">recommendations </span>
   <span class="font10">related </span>
   <span class="font10">removed </span>
   <span class="font10">should </span>
   <span class="font10">solid; </span>
   <span class="font10">strategy </span>
   <span class="font10">these </span>
   <span class="font10">through </span>
   <span class="font10">under </span>
   <span class="font10">used </span>
   <span class="font10">which </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.., </span>
   <span class="font10">//EC </span>
   <span class="font10">AMR. </span>
   <span class="font10">Gram-negative </span>
   <span class="font10">Our </span>
   <span class="font10">States </span>
   <span class="font10">[], </span>
   <span class="font10">actions </span>
   <span class="font10">against </span>
   <span class="font10">aim </span>
   <span class="font10">and/or </span>
   <span class="font10">antibacterial </span>
   <span class="font10">approved </span>
   <span class="font10">assessed </span>
   <span class="font10">because </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">bronchitis </span>
   <span class="font10">change </span>
   <span class="font10">children </span>
   <span class="font10">class </span>
   <span class="font10">colistin </span>
   <span class="font10">common </span>
   <span class="font10">conception </span>
   <span class="font10">content. </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">design; </span>
   <span class="font10">differences </span>
   <span class="font10">each </span>
   <span class="font10">em; </span>
   <span class="font10">evidence </span>
   <span class="font10">fosfomycin </span>
   <span class="font10">further </span>
   <span class="font10">including </span>
   <span class="font10">initiated </span>
   <span class="font10">intellectual </span>
   <span class="font10">medicines. </span>
   <span class="font10">oral </span>
   <span class="font10">practice </span>
   <span class="font10">provide </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">restriction </span>
   <span class="font10">risk </span>
   <span class="font10">safety </span>
   <span class="font10">sections </span>
   <span class="font10">several </span>
   <span class="font10">support </span>
   <span class="font10">teicoplanin, </span>
   <span class="font10">triggered </span>
   <span class="font10">updated </span>
   <span class="font10">went </span>
  </p>
 </body>
</html>
